Molecular Diagnostics
Genetic Mutation Identified for Childhood Kidney Cancer
The underlying mechanism that causes aneuploidy might be important in understanding cancer risk and not solely having the wrong number of chromosomes in a cell. It is an important development that provides valuable information about the fundamental biology of cancer. More...13 Jun 2017
Rapid Molecular Test Diagnoses Multiple Sclerosis
A pioneering blood test has been introduced that speeds up multiple sclerosis (MS) diagnosis to just seven days. Current testing methods such as magnetic resonance imaging scans take much longer to reach a diagnosis because they rely on measuring the progress of irreversible neurological damage. More...07 Jun 2017
Rare Infection in Transplant Recipients Linked to Donors
The way in which heart and lung transplant recipients acquired a specific species of bacteria, Mycoplasma hominis, had been previously undefined, and the bacterium was difficult to test for and detect. Originally, this bacterium was considered to reside exclusively in, and be a potential pathogen of the area of the reproductive and urinary organs. More...01 Jun 2017
Biomarkers Revealed for Cognitive Impairment in PD
Biomarkers have been identified that could predict the cognitive impairment typical of Parkinson's Disease (PD), a neurodegenerative disease that affects about half a million people in the USA, with approximately 50,000 people receive a PD diagnosis every year. More...31 May 2017
Untethered Proteins Could Help Diagnose MKD
Mevalonate Kinase Deficiency (MKD), also known as HIDS (hyper IgD syndrome), is a rare genetic condition that affects approximately 200 individuals worldwide. It is a spectrum of disease, with complications that range from mild to severe. MKD is one of more than 8,000 known rare and genetic conditions, which, although individually uncommon, collectively affect up to 10% of the population. More...30 May 2017
Haptoglobin Genotyping Test Enables Key Diabetes Treatment
A breakthrough ELISA kit, based on the Haptoglobin 2-2 (Hp 2-2) protein marker, can identify diabetes patients at higher risk of developing lethal cardiovascular disease or renal failure, thereby enabling them to take Vitamin E, a nutritional supplement shown to be of great benefit to them but posing harm to the remaining non HP 2-2 diabetic population. A CE mark application for the test is currently in progress, with FDA certification planned for the US market. More...29 May 2017
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Gel Cards
DG Gel Cards
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
In Other News
Recurrent Mutation Linked to Childhood Blindness
Blood Sample Storage Evaluated for PEA Analysis
Metabolic Approach Helps Determine Risk of AD
Alzheimer’s Disease Progression Predicted by Gene Mutation
Pathogens Help Diagnose Fatty Liver Disease
Gene Sequencing Reveals Mutations in Endometriosis
Molecular Test Predicts Blood Cancer Patient Survival
Solvent Interaction Analysis of PSA Reduces Need for Biopsies
Elevated Levels of Beta-2 Microglobulin Linked to Increased Stroke Risk
Low Levels of Protein Linked to Cognitive Decline
Test Predicts Benefit of Targeted Cancer Treatments
Genomic Duplication Responsible for Rare Skin Disease
Typhoid Fever Victims Present Unique Metabolomic Profile
Child Biomarkers Linked to BD Parents
Immune Response Differentiates Malaria from Other Infections
POC Test Advances Hepatitis C Diagnosis
Genes Should Be Screened for Stem Cell Transplants
Genetics Are Key to Lowering Bone Fracture Risk
Novel Fluorescent Technique Detects Early Stage Glaucoma
Low Levels of 1-Asparaginase Predict Cancer Recurrence
Multigene Test Extends Life Expectancy for Cancer Patients
Bordetella Direct Test Receives FDA Clearance
Bacterial Pathogens Panel Receives CE Marking
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.